← Back to Search

Shock Wave Therapy

Shockwave Treatment for Connective Tissue Disorder

N/A
Waitlist Available
Research Sponsored by Cynosure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days post treatment
Awards & highlights

Summary

This trial is testing the ViaSure device, which uses shock waves to help heal tissues. Up to 50 participants will be involved across two locations. The study will check how well the device works and how tissues respond to the treatment. Participants may receive up to five treatments and will have follow-up visits for a few months after their last treatment. Shock wave therapy has been used in various medical treatments, including for rotator cuff disease and low back pain, but its efficacy and safety remain uncertain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
# of Subjects With Altered Gene Expression

Trial Design

1Treatment groups
Experimental Treatment
Group I: Shockwave DeviceExperimental Treatment1 Intervention
The Shockwave device will be used on multiple areas of the body for the purpose of treating connective tissue.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Shockwave Treatment
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Cynosure, Inc.Lead Sponsor
51 Previous Clinical Trials
1,231 Total Patients Enrolled
Jennifer CiviokStudy DirectorCynosure, Inc.
16 Previous Clinical Trials
487 Total Patients Enrolled
~1 spots leftby Oct 2025